MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 29 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,970 | +86.7% | 2,250,000 | 0.0% | 0.14% | +76.9% |
| Q1 2023 | $1,591 | -99.9% | 2,250,000 | 0.0% | 0.08% | -12.4% |
| Q4 2022 | $1,687,500 | -12.9% | 2,250,000 | 0.0% | 0.09% | -18.3% |
| Q3 2022 | $1,937,000 | -23.1% | 2,250,000 | 0.0% | 0.11% | -31.9% |
| Q2 2022 | $2,520,000 | -87.2% | 2,250,000 | -63.9% | 0.16% | -77.0% |
| Q2 2021 | $19,739,000 | -5.9% | 6,226,673 | 0.0% | 0.70% | -2.2% |
| Q1 2021 | $20,984,000 | -5.9% | 6,226,673 | 0.0% | 0.71% | -0.7% |
| Q4 2020 | $22,291,000 | +111.1% | 6,226,673 | +54.5% | 0.72% | +96.4% |
| Q3 2020 | $10,558,000 | -14.4% | 4,029,649 | 0.0% | 0.36% | -32.7% |
| Q2 2020 | $12,331,000 | +381.5% | 4,029,649 | +64.4% | 0.54% | +209.7% |
| Q1 2020 | $2,561,000 | – | 2,450,543 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |